STF Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Buy |
4,095
+96
| +2% | +$42.7K | 0.72% | 35 |
|
|
2025
Q1 | $1.94M | Sell |
3,999
-22
| -0.5% | -$10.7K | 0.93% | 27 |
|
|
2024
Q4 | $1.62M | Buy |
4,021
+320
| +9% | +$129K | 0.73% | 31 |
|
|
2024
Q3 | $1.72M | Sell |
3,701
-420
| -10% | -$195K | 0.78% | 27 |
|
|
2024
Q2 | $1.93M | Sell |
4,121
-201
| -5% | -$94.2K | 0.81% | 30 |
|
|
2024
Q1 | $1.81M | Buy |
4,322
+52
| +1% | +$21.7K | 0.78% | 30 |
|
|
2023
Q4 | $1.74M | Buy |
4,270
+43
| +1% | +$17.5K | 0.82% | 29 |
|
|
2023
Q3 | $1.47M | Buy |
4,227
+2,562
| +154% | +$891K | 0.78% | 31 |
|
|
2023
Q2 | $586K | Sell |
1,665
-1,286
| -44% | -$453K | 0.63% | 31 |
|
|
2023
Q1 | $930K | Buy |
2,951
+1,238
| +72% | +$390K | 0.63% | 34 |
|
|
2022
Q4 | $495K | Buy |
+1,713
| New | +$495K | 0.71% | 34 |
|